FP
Highly rated in
13
conditions
Highly rated in
13
conditions
Check Dr. Finn B. Petersen's experience treating your condition:
About Dr. Finn B. Petersen

Finn Petersen is a Hematologist Oncology specialist and a Hematologist in Boise, Idaho. Petersen has been practicing medicine for over 44 years and is highly rated in 13 conditions, according to our data. His top areas of expertise are Acute Myeloblastic Leukemia with Maturation, Acute Myeloid Leukemia AML, Childhood Acute Myeloid Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration. He is licensed to treat patients in Utah. Petersen is currently accepting new patients.

His clinical research consists of co-authoring 29 peer reviewed articles and participating in 1 clinical trial in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Finn B. Petersen it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Finn B. Petersen accepts the following insurance:

  •  Ambetter
  •  Montana Health Cooperative
  •  Moda Health

Call to see if your plan is accepted.
Locations
100 E Idaho St, Suite 200, Boise, ID 83712
Other Locations
500 W Fort St, Boise, ID 83702
Background & Education
Graduate Institution
Other, 1978
Specialties
Hematology Oncology
Hematology
Oncology
Licenses
Internal Medicine in UT
Hospital Affiliations
LDS Hospital
Providence VA Medical Center
Legacy Good Samaritan Medical Center
St Lukes Boise Medical Center
Languages Spoken
English
Danish
German
Swedish
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


1 Clinical Trials

Low-Dose TBI Dose Escalation to Decrease Risks of Progression and Graft Rejection After Hematopoietic Cell Transplantation With Nonmyeloablative Conditioning as Treatment for Untreated Myelodysplastic Syndrome or Myeloproliferative Disorders - A Multi-Center Trial
Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors